| Phase 1 | 4 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06519370 | FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or… | Triple Negative Breast Cancer | Active, Not Recruiting | 2026-01-22 |
| Phase 2 | ||||
| NCT05171894 | A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With… | Port-wine Birthmarks | Recruiting | 2026-03-03 |
| Phase 1 | ||||
| NCT05914545 | A Study of FZ-AD004 in Patients With Advanced Solid Tumors | Advanced and Metastatic Solid Tumor | Recruiting | 2026-08-28 |
| NCT06424665 | A Study of FZ-AD005 in Patients With Advanced Solid Tumors | Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma) | Recruiting | 2026-03-04 |
| NCT07455045 | A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG) | High Grade Glioma (III or IV) | Not Yet Recruiting | 2026-03-06 |
| NCT05174637 | A Study of FDA018-ADC in Patients With Advanced Solid Tumors | Advanced/ Metastatic Solid Tumors | Active, Not Recruiting | 2026-01-23 |
Breast Cancer (1) · Glioblastoma (1) · Glioma (1) · Lung Cancer (1) · Small Cell Lung Cancer (1) · Triple-Negative Breast Cancer (1)